Search

You searched for "wetting"

827 results found

The EP2 receptor – a novel target for prostate cancer?

1 July 2014 | | URO - Basic Science Research, URO - Urologic Oncology
This basic science paper sets out to evaluate the effects that celecoxib, a selective cyclo-oxygenase-2 (COX-2) inhibitor, have on prostate cancer cell lines and evaluated the mechanisms behind these effects. COX-2 induces the production of prostaglandins, which promote cell proliferation...
The BMJ cover

Urinary tract infections and antibiotics – the debate goes on

5 November 2019 | | URO - Functional / Reconstructive Urology, URO - Infection
A large number of hospital patients and primary care patients suffer from recurrent urinary tract infection (UTI) and urosepsis. Some of these patients end up in intensive care units with multi-organ failure. New draft guidance from the National Institute for...

Urinary Stones – Medical and Surgical Management

1 March 2015 | | URO - Endourology & Stones, URO - Functional / Reconstructive Urology, URO - Trauma & Emergency
This book is nicely adapted to cover both the medical and surgical management of urinary stone disease. Those chapters dealing with the surgical management of stone disease are dealt with unsurprisingly well – delivered with a relaxed and conversational prose...

Button vesicostomy

1 July 2014 | | URO - Paediatric Urology
Poor bladder emptying often requires clean intermittent catheterisation (CIC). In significant numbers of children CIC is not possible for a variety of reasons and an alternative is needed. This paper reviews a single centre’s usage of the vesicostomy button over...

Menopause in Aesthetics 2025

7 February 2025
Menopause in Aesthetics (MiA) returns for its highly anticipated third year! After two groundbreaking events, MiA 2025 promises to push the boundaries of aesthetic medicine and menopause care. This ever-evolving conference and exhibition puts you at the forefront of one...

The conservative assessment and treatment of mixed urinary and anal incontinence in women: a multidisciplinary approach

1 September 2019 | | URO - Functional / Reconstructive Urology, URO - Neurourology
Mixed urinary incontinence Urinary incontinence (UI) is considered to be a highly prevalent condition; however, depending upon the definitions used, actual reported prevalence rates can vary significantly. The International Consultation on Incontinence (ICI) review [1], reported unadjusted prevalence estimates for...

Sarcomatoid renal cell carcinoma

1 September 2017 | | URO - Urologic Oncology
Renal cell carcinoma (RCC) represents 2-3% of all cancers [1]. It is an adenocarcinoma making up 85% of all renal malignancies. Sarcomatoid transformation is a microscopically identified feature of RCC accounting for 5% of all RCCs [2]. Known as sarcomatoid...

An effective new solution for chronic pelvic pain patients

4 March 2022 | Research & Development
The Feel Free Programme is a safe, effective innovation which addresses the overwhelming caseload pressure on clinics because patients can start right now...

Prostate Cancer: 'A Marathon, Not a Sprint' Podcast

7 May 2025
Men Only was established to offer a platform for men to openly discuss issues important to them. This platform provides a safe space for open dialogue and exploration of topics that are frequently marginalised in mainstream conversations. The platform aims...

Of gods and men

7 July 2020 | | URO - Technology
In this series of articles I am going to show you some of the exhibits contained in the Museum of Urology, hosted on the BAUS website (www.baus.org.uk). One of the most fascinating aspects of early Ancient Greek culture is the...

What’s in a name?

1 March 2016 |
Kate Granger is a doctor and the founder of the #hellomynameis campaign; she is also a cancer patient. In this article she explains why she started the campaign, and why patient-centred care starts with an introduction. Chris and me the...

The role of PET-CT imaging in prostate cancer

4 October 2021 | | URO - Urologic Oncology
Prostate cancer (PCa) is the second most common cancer in the UK, with 43,000 cases in 2017-18 [1,2]. Accurate primary staging and the detection of suspected recurrence following treatment is vital for directing management and predicting prognosis. This has conventionally...